Associate Director, Commercial Accounting & Operations
Denali Therapeutics
Summary
Denali Therapeutics Inc. is a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier (BBB) using its proprietary TransportVehicle™ platform. With the first FDA-approved biologic specifically designed to cross the BBB, a clinically validated delivery platform and a growing portfolio of therapeutic candidates across all stages of development, we are advancing toward our goal of delivering effective medicines to transform the lives of people living with neurodegenerative diseases, lysosomal storage disorders and other serious diseases.
Job description
This role owns day-to-day execution across the commercial revenue cycle for our first commercial product, including order management, order-to-cash, accounts receivable and credit management, pricing operations, revenue recognition and gross-to-net reserves, and commercial-cycle close and controls. As the commercial footprint expands across products and geographies, this role is expected to build scalable, well-controlled processes rather than simply operate existing ones. This is a self-contributor role which expects to expand in the future as Denali scale and grow across the pipeline of drug candidates.
Key Accountabilities/Core Job Responsibilities
Order Management, Revenue Recognition and Gross-to-Net (GTN)
- Oversee daily order management, including order review and release, credit and compliance holds, pricing conditions, delivery confirmation, and billing execution in SAP.
- Serve as the finance process owner for the end-to-end order-to-cash process, from customer master and contract setup through invoicing and cash application, all the way to closing the books and finalizing accounting reconciliations.
- Manage the operational and financial interface with the third-party logistics provider, specialty distributors, and international distribution partners, including order flow, delivery reporting, fee and chargeback submissions, and monthly reconciliations.
- Lead the preparation, analysis, and review of GTN and the related roll-forward.
- Prepare revenue and GTN inputs for external reporting, including the product revenue footnote, GTN roll-forward tables, and supporting tie-outs for 10-Q and 10-K filings.
Treasury Operations, Accounts Receivable and Credit Management
- Manage accounts receivable operations, including aging review, collections cadence, cash application, deduction and dispute resolution.
- Develop, implement and maintain the policy around allowance for credit losses.
- Assist with treasury operations, including daily cash positioning, bank account administration and access, and preparation of short-term cash forecasts supporting liquidity management.
Technical Accounting and Contracts Review
- Review commercial agreements for financial terms, revenue recognition implications, and downstream system and process impacts.
- Assist with preparation of technical accounting memos on revenue and commercial arrangements, including ASC 606 analyses, new contract structures, and implementation of new accounting standards.
- Maintain the revenue recognition accounting policy and related position papers and support their review with the Controller organization and external auditors.
- Serve as process owner for commercial-cycle SOX controls.
Qualifications/Skills
- Typically requires a Bachelor's degree in Accounting, Finance, or a related field and 12+ years of progressive accounting and finance experience, including commercial and revenue accounting under ASC 606.
- Demonstrated ownership of order-to-cash operations, including order management, accounts receivable, collections, and customer credit, at a subject-matter-expert level.
- Strong working knowledge of U.S. GAAP, SOX compliance, and public company reporting requirements.
- Demonstrated ability to partner cross-functionally with Commercial, Market Access, Supply Chain, IT, Legal, and Tax, and to communicate financial concepts to non-finance stakeholders.
- Ability to operate effectively in a fast-paced, early commercial environment where processes are still being built.
Preferred Experience
- CPA strongly preferred (active or inactive)
- Big Four public accounting experience
- International commercial experience
- Advanced Excel skills and comfort working with large transactional data sets and reconciliations
- Demonstrated commitment to actively leveraging AI tools and proactively identifying opportunities to integrate AI into processes and workflows
- Familiarity with U.S. government pricing programs, including Medicaid, 340B, and Medicare Part D
- Experience with SAP, FloQast, Workiva
- Experience in a pharmaceutical, biotechnology, or life sciences company
Requirements
- Bachelor's degree in Accounting, Finance, or a related field
- 12+ years of progressive accounting and finance experience
- Commercial and revenue accounting under ASC 606
- Demonstrated ownership of order-to-cash operations at a subject-matter-expert level
- Strong working knowledge of U.S. GAAP
- SOX compliance knowledge
- Public company reporting requirements knowledge
- Ability to partner cross-functionally with Commercial, Market Access, Supply Chain, IT, Legal, and Tax
- Ability to communicate financial concepts to non-finance stakeholders
- Ability to operate in a fast-paced, early commercial environment
Benefits
- 401(k)
- Healthcare coverage
- ESPP
Company overview
Denali Therapeutics is a pioneering biotechnology company focused on developing innovative therapeutics for neurodegenerative and lysosomal storage diseases. Founded in 2015 and headquartered in South San Francisco, California, the company has developed a proprietary TransportVehicle™ (TV) platform designed to enable biotherapeutics to cross the blood-brain barrier, addressing one of the most significant challenges in treating central nervous system disorders. Denali's pipeline includes promising candidates for conditions such as Hunter syndrome (MPS II), Parkinson's disease, frontotemporal dementia, Sanfilippo syndrome (MPS IIIA), and MPS I, with several programs in advanced clinical development stages. The company collaborates with major pharmaceutical partners including Biogen and Sanofi, leveraging its platform technology to create a new class of barrier-crossing therapeutics. With approximately 500-1,000 employees and operations spanning multiple locations including Salt Lake City, Denali Therapeutics represents a leading force in neuroscience drug development, combining deep scientific expertise with a patient-centric approach to transform treatment paradigms for serious neurological conditions.